Immune Disease Institute, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Immune Disease Institute, Inc..The latest application filed is for "natural igm antibodies and inhibitors thereof".

Company Profile

0.9.34

Immune Disease Institute, Inc. - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Natural Igm Antibodies And Inhibitors Thereof App 20140127214 - Carroll; Michael C. ; et al.	2014-05-08
Regulators Of Nfat And/or Store-operated Calcium Entry App 20140093542 - Rao; Anjana ; et al.	2014-04-03
Efficient Protein Expression In Vivo Using Modified Rna (mod-rna) App 20140073687 - Chien; Kenneth R. ; et al.	2014-03-13
Regulators Of Nfat And/or Store-operated Calcium Entry App 20130158101 - Rao; Anjana ; et al.	2013-06-20
Adamts13-containing Compositions Having Thrombolytic Activity App 20130136732 - Wagner; Denisa ; et al.	2013-05-30
Targeted Delivery To Leukocytes Using Protein Carriers App 20130129752 - Peer; Dan ; et al.	2013-05-23
Regulators of NFAT Grant 8,399,185 - Rao , et al. March 19, 2	2013-03-19
Regulators of NFAT and/or store-operated calcium entry Grant 8,394,778 - Rao , et al. March 12, 2	2013-03-12
Method For Screening Receptors/ligands Interactions App 20130040845 - Springer; Timothy A. ; et al.	2013-02-14
Sustained Polypeptide Expression From Synthetic, Modified Rnas And Uses Thereof App 20120322864 - Rossi; Derrick ; et al.	2012-12-20
Sustained Polypeptide Expression From Synthetic, Modified Rnas And Uses Thereof App 20120322865 - Rossi; Derrick ; et al.	2012-12-20
Stromal Interacting Molecule Knockout Mouse And Uses Thereof App 20120272343 - Oh-Hora; Masatsugu ; et al.	2012-10-25
Assay For Orai Calcium Channel Regulators App 20120264231 - Hogan; Patrick ; et al.	2012-10-18
Method Of Delivering Rna Interference And Uses Thereof App 20120258534 - Lieberman; Judy ; et al.	2012-10-11
Method of delivering RNA interference and uses thereof Grant 8,168,601 - Lieberman , et al. May 1, 2	2012-05-01
Therapeutic And Diagnostic Strategies App 20120059043 - Lieberman; Judy ; et al.	2012-03-08
Sustained Polypeptide Expression From Synthetic, Modified Rnas And Uses Thereof App 20120046346 - Rossi; Derrick ; et al.	2012-02-23
miRNA TARGETS App 20120040851 - Lieberman; Judy ; et al.	2012-02-16
Regulators Of Nfat App 20110269174 - RAO; Anjana ; et al.	2011-11-03
Regulators of NFAT and/or store-operated calcium entry Grant 8,048,864 - Rao , et al. November 1, 2	2011-11-01
Selective Oxidation Of 5-methylcytosine By Tet-family Proteins App 20110236894 - Rao; Anjana ; et al.	2011-09-29
Integrin alpha L I domain mutants with increased binding affinity Grant 8,021,668 - Jin , et al. September 20, 2	2011-09-20
Methods Of Delivery Of Agents To Leukocytes And Endothelial Cells App 20110177155 - Peer; Dan ; et al.	2011-07-21
Compositions And Methods For Inhibition Of Retroviruses App 20110142854 - Yan; Nan ; et al.	2011-06-16
siRNA microbicides for preventing and treating diseases Grant 7,943,589 - Lieberman , et al. May 17, 2	2011-05-17
Stromal Interacting Molecule Knockout Mouse And Uses Thereof App 20100323371 - Oh-Hora; Masatsugu ; et al.	2010-12-23
Treatment Or Prevention Of Inflammation By Targeting Cyclin D1 App 20100285002 - Peer; Dan ; et al.	2010-11-11
Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases Grant 7,816,490 - Hogan , et al. October 19, 2	2010-10-19
Method for Delivery Across the Blood Brain Barrier App 20100233084 - Narasimhaswamy; Manjunath ; et al.	2010-09-16
Targeted Delivery of siRNA App 20100209440 - Shankar; Premlata ; et al.	2010-08-19
Stabilized Low Affinity Conformation Of Integrins For Drug Discovery App 20100167418 - Springer; Timothy A. ; et al.	2010-07-01
Inhibition of gene expression using RNA interfering agents Grant 7,696,179 - Lieberman , et al. April 13, 2	2010-04-13
Targeted Delivery To Leukocytes Using Non-protein Carriers App 20100008937 - Peer; Dan ; et al.	2010-01-14
Von Willebrand Factor (vwf) Inhibitors For Treatment Or Prevention Of Infarction App 20090317375 - Wagner; Denisa ; et al.	2009-12-24
Method Of Producing Immunoliposomes And Compositions Thereof App 20090232730 - Peer; Dan ; et al.	2009-09-17
SKN-1 and GSK-3 genes and proteins Grant 7,572,949 - Blackwell , et al. August 11, 2	2009-08-11
Regulators of NFAT App 20090178146 - Rao; Anjana ; et al.	2009-07-09
Method to Treat Flavivirus Infection with siRNA App 20090047338 - Swamy; Manjunath N. ; et al.	2009-02-19
siRNA MICROBICIDES FOR PREVENTING AND TREATING DISEASES App 20090022783 - Lieberman; Judy ; et al.	2009-01-22
Integrin Alpha L I Domain Mutants with Increased Binding Affinity App 20080311130 - Jin; Moonsoo ; et al.	2008-12-18
Method for Treating and Preventing Ischemia-Reperfusion Injury Using Rna Interfering Agent App 20080227733 - Lieberman; Judy ; et al.	2008-09-18

Company Registrations

NCAGE Code	3WRC2	IMMUNE DISEASE INSTITUTE, INC.
CAGE Code	3WRC2	IMMUNE DISEASE INSTITUTE, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.